ADC-001

N/A

Report date: 2025/08/27 17:31:46

Base Information

Drug NameADC-001
Drug Alias NameADC-001
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovoBiome SAS
China Registration ClassN/A

Develop Information

Active CompaniesNovoBiome SAS
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A